Medicare Enrolled

Dr. Thamilvani Thiruvasahar, MD

Internal Medicine · Mckinney, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1445 HERITAGE DR STE A, Mckinney, TX 75069
9725479700
In practice since 2008 (17 years)
NPI: 1790948768 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thiruvasahar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thiruvasahar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thiruvasahar

Dr. Thamilvani Thiruvasahar is an internal medicine specialist in Mckinney, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Thiruvasahar performed 4,200 Medicare services across 332 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thiruvasahar received a total of $16,220 from 44 pharmaceutical and/or device companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thiruvasahar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 8% volume in TX $16,220 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,200
Medicare services
Top 8% in TX for internal medicine
332
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~247 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,360 $19 $50
Office visit, established patient (30-39 min) 323 $96 $300
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 184 $53 $183
Steroid injection (triamcinolone) 105 $1 $10
Office visit, established patient (20-29 min) 74 $67 $200
Infusion, normal saline solution, 250 cc 56 $1 $20
Office visit, established patient, complex (40-54 min) 43 $138 $380
New patient office visit (45-59 min) 33 $124 $430
Joint injection, major joint 22 $50 $160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
87.4% medium
11.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,220
Total received (2018-2024)
Avg $2,317/year across 7 years
Top 6% in TX for internal medicine
44
Companies
488
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,269 (88.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,821 (11.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$130 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,005
2023
$3,862
2022
$1,699
2021
$1,585
2020
$1,528
2019
$1,371
2018
$1,169

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,554
Janssen Scientific Affairs, LLC
$1,446
Chiesi USA, Inc.
$1,200
Janssen Biotech, Inc.
$1,176
ABBVIE INC.
$913
PFIZER INC.
$776
AbbVie Inc.
$754
AbbVie, Inc.
$653
GlaxoSmithKline, LLC.
$616
Lilly USA, LLC
$610
Horizon Therapeutics plc
$585
GENZYME CORPORATION
$525
Mallinckrodt Hospital Products Inc.
$494
Novartis Pharmaceuticals Corporation
$442
UCB, Inc.
$428
AstraZeneca Pharmaceuticals LP
$278
E.R. Squibb & Sons, L.L.C.
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$236
Radius Health, Inc.
$224
Aurinia Pharma U.S., Inc.
$131
Sentynl Therapeutics, Inc.
$130
Shire North American Group Inc
$105
McKesson Medical-Surgical, Inc.
$96
Alexion Pharmaceuticals, Inc.
$63
Organon LLC
$60
Hikma Pharmaceuticals USA
$42
BIOTRONIK NRO, Inc.
$41
Flexion Therapeutics, Inc.
$41
SCILEX PHARMACEUTICALS INC.
$37
Genentech USA, Inc.
$36
ANI Pharmaceuticals, Inc.
$31
Fresenius Kabi USA, LLC
$31
Celgene Corporation
$27
Pharmacyclics LLC, an AbbVie Company
$25
Takeda Pharmaceuticals U.S.A., Inc.
$22
Fidia Pharma USA Inc.
$22
Mallinckrodt Enterprises LLC
$22
Ferring Pharmaceuticals Inc.
$19
Ultragenyx Pharmaceutical Inc.
$17
Sobi, Inc
$17
Exeltis, USA Inc.
$16
Teva Pharmaceuticals USA, Inc.
$16
SOBI, INC
$13
SANOFI-AVENTIS U.S. LLC
$12
Top 3 companies account for 38.2% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Amitiza · BENLYSTA · BIOTRONIK · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · HYMOVIS · Humira · IDACIO · IMBRUVICA · INFLECTRA · JUXTAPID · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · NUCALA · OFEV · ORENCIA · Otezla · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Truxima · Tymlos · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in TX.

Equivalent to $386 per 100 Medicare services performed
Looking for an internal medicine specialist in Mckinney?
Compare internal medicine physicians in the Mckinney area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,028
Per 100K population
92.1
County median income
$117,588
Nearest hospital
MEDICAL CENTER OF MCKINNEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Thiruvasahar is a mixed practice specialist, with above-average Medicare volume (top 8% in TX), with low-engagement industry engagement in the top 6% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Thiruvasahar experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Thiruvasahar performed 3,360 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thiruvasahar receive payments from pharmaceutical companies?
Yes. Dr. Thiruvasahar received a total of $16,220 from 44 companies across 488 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thiruvasahar's costs compare to other internal medicine physicians in Mckinney?
Dr. Thiruvasahar's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Thiruvasahar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →